Literature DB >> 7494023

Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.

M Skulnick1, G W Small, P Lo, M P Patel, C R Porter, D E Low, S Matsumura, T Mazzulli.   

Abstract

We evaluated the reproducibility with which technologists perform and interpret the E test (AB Biodisk, North America, Inc., Piscataway, N.J.) for determining the susceptibility of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone. Four technologists prepared E test assays to test 124 isolates of S. pneumoniae. Each technologist then interpreted the results of the E test blinded to the interpretation of the other technologists. In addition, E test results were compared with the reference method of broth microdilution. Intraobserver and interobserver agreement were assessed by use of the kappa statistic. Interpretation of the E test and broth microdilution results showed substantial to excellent agreement, with kappa values ranging from 0.878 to 0.987. Compared with broth microdilution, no very major errors and only four major errors were made with the E test. Most minor errors with penicillin and ceftriaxone occurred for isolates with intermediate or high-level resistance, whereas for cefotaxime the minor errors were more evenly distributed between susceptible and intermediate resistance and between intermediate and high-level resistance. These results indicate that there is good agreement between technologists for the interpretation of the E test when testing the susceptibility of S. pneumoniae to penicillin, cefotaxime, and ceftriaxone and that the results of the E test agree with those of broth microdilution.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494023      PMCID: PMC228405          DOI: 10.1128/jcm.33.9.2334-2337.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Reproducibility of interpretation of Gram-stained vaginal smears for the diagnosis of bacterial vaginosis.

Authors:  T Mazzulli; A E Simor; D E Low
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

2.  Emergence of multiply resistant pneumococci.

Authors:  M R Jacobs; H J Koornhof; R M Robins-Browne; C M Stevenson; Z A Vermaak; I Freiman; G B Miller; M A Witcomb; M Isaäcson; J I Ward; R Austrian
Journal:  N Engl J Med       Date:  1978-10-05       Impact factor: 91.245

3.  Screening pneumococci for penicillin resistance.

Authors:  J M Swenson; B C Hill; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

4.  Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; J M Swenson; F C Tenover; M J Ferraro; J A Hindler; P R Murray
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  Meningitis due to ceftriaxone-resistant Streptococcus pneumoniae.

Authors:  J R Lonks; M R Durkin; A N Meyerhoff; A A Medeiros
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

6.  Clinical biostatistics. LIV. The biostatistics of concordance.

Authors:  M S Kramer; A R Feinstein
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

7.  Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae.

Authors:  D L Kiska; A Kerr; M C Jones; N N Chazotte; B Eskridge; S Miller; M Jordan; C Sheaffer; P H Gilligan
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

8.  Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin.

Authors:  J I Ward; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

9.  Comparison of three commercial MIC systems, E test, fastidious antimicrobial susceptibility panel, and FOX fastidious panel, for confirmation of penicillin and cephalosporin resistance in Streptococcus pneumoniae.

Authors:  K K Krisher; A Linscott
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

10.  Streptococcus pneumoniae resistant to penicillin and chloramphenicol.

Authors:  P C Appelbaum; A Bhamjee; J N Scragg; A F Hallett; A J Bowen; R C Cooper
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

View more
  4 in total

1.  Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci.

Authors:  Liselotte Högberg; Patricia Geli; Håkan Ringberg; Eva Melander; Marc Lipsitch; Karl Ekdahl
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

2.  Comparison of BD phoenix to vitek 2, microscan MICroSTREP, and Etest for antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  Scott A Mittman; Richard C Huard; Phyllis Della-Latta; Susan Whittier
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

3.  Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.

Authors:  M Lovgren; L Dell'Acqua; R Palacio; G Echániz-Aviles; A Soto-Noguerón; E Castañeda; C I Agudelo; I Heitmann; M C Brandileone; R C Zanella; A Rossi; J Pace; J A Talbot
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Limited spread of penicillin-nonsusceptible pneumococci, Skåne County, Sweden.

Authors:  Eva Melander; Hans-Bertil Hansson; Sigvard Mölstad; Kristina Persson; Håkan Ringberg
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.